Navigation Links
Genesis Biopharma to Hold Business Update Conference Call on June 29
Date:6/22/2011

LOS ANGELES, June 22, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted cancer therapies, today announced that it will hold a conference call with the investment community on Wednesday, June 29, 2011 at Noon Eastern (9:00 a.m. Pacific).  The Company's Chairman and Chief Executive Officer, Anthony J. Cataldo, will provide an update on the business, and discuss the clinical and commercial development plans for the Company's new autologous cell therapy product candidate, Contego™, for the treatment of Stage IV metastatic melanoma.  There will also be a question and answer session following the presentation.

Individuals interested in listening to the conference call may do so by dialing 888-634-9408 for domestic callers, or 706-679-0879 for international callers, or from the webcast on the investor relations section of the Company's Web site at www.genesis-biopharma.com.  A slide presentation will accompany the call and webcast, and will be available on the Company website.

A telephone replay will be available through July 1, 2011 by dialing 800-642-1687 for domestic callers, or 706-645-9291 for international callers, and entering the Conference ID #: 78126182.  The webcast will be available on the Company's Web site for 60 days following the completion of the call.

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer therapies. For more information about the company, visit www.genesis-biopharma.com.

Forward-Looking Statements

The foregoing announcement contains forward-looking statements that can be identified by such terminology as "expects", "hopes", "potential", "suggests", "bodes", "may", "should", "could", or similar expressions.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements.  In particular, management's expectations regarding future research, development and/or commercial results could be affected by, among other things, uncertainties relating to clinical trials and product development; availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and competition in general.  Forward-looking statements speak only as of the date they are made.  The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.


'/>"/>
SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference
2. Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes
3. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
4. CryoLife Announces Completion of Acquisition of Cardiogenesis
5. CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
6. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
7. Cardiogenesis Reports First Quarter 2011 Results
8. CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
9. ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011
10. Cardiogenesis Corporation to Report 2011 First Quarter Results on May 4th
11. CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... , July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, ... program to patients who suffer from painful intercourse and other painful pelvic ... vaginal atrophy due to menopause. ... VuVatech LLC ... created by Sarasota, Florida -based start-up company, VuVatech LLC, ...
(Date:7/10/2017)... , July 10, 2017 The Institute ... test methods, is the recipient of a VITROCELL® inhalation ... PETA International Science Consortium. The device, which is designed ... to expose human lung cells to airborne test materials ... will use the VITROCELL® system for testing combustible tobacco ...
(Date:7/10/2017)... RESEARCH TRIANGLE PARK, N.C. , July 10, 2017 ... of a $5m Convertible Note to support the development ... led by Tencent Holdings Limited, a leading Chinese Internet ... Center. This funding will advance multiple infectious disease product ... Founded by Dr. ...
Breaking Medicine Technology:
(Date:7/18/2017)... ... July 19, 2017 , ... USHEALTH Group, Inc. ... Initiative in the prestigious CEO World Awards®. The coveted annual CEO World ... and services, CEO case studies, corporate social responsibility, and milestones from every major ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... Its Treatments during Pregnancy , studies take a closer look at maternal depression, ... developing baby with one study showing newer medications may be safer choices. , ...
(Date:7/17/2017)... Connecticut (PRWEB) , ... July 17, 2017 , ... McGraw ... Enhance Patient Care and Train Next Generation of Healthcare Clinicians , NORWALK, Connecticut ... McGraw-Hill, is continuing its legacy of investing in community health by pledging up to ...
(Date:7/17/2017)... ... 2017 , ... Altec Products, Inc., a leader in enterprise document ... in Atlanta, Georgia. The four-day training session, which begins today and continues through ... more efficiently and effectively. , Covering topics such as Smart Form Toolkit, Security, ...
(Date:7/17/2017)... Pomona, California (PRWEB) , ... July 17, 2017 ... ... a “Great College to Work For” by the Chronicle of Higher Education for ... consecutive year. , WesternU, which has campuses in Pomona, California and Lebanon, Oregon, ...
Breaking Medicine News(10 mins):